Naglaa Shoukry Profile
Naglaa Shoukry

@naglaa_shoukry

Followers
496
Following
565
Media
46
Statuses
535

Professor, University of Montreal and CRCHUM, Director of the Canadian Network on Hepatitis C (CanHepC)

Montréal, Québec
Joined December 2011
Don't wanna be here? Send us removal request.
@naglaa_shoukry
Naglaa Shoukry
12 days
RT @J_Immunol: The June cover image is from @Naglaa_Shoukry at @CRCHUM and their work demonstrating that treating mice with the RORγt inhib….
0
3
0
@naglaa_shoukry
Naglaa Shoukry
2 months
RT @ImmunologyAAI: New data from @Naglaa_Shoukry at @CRCHUM found that treating mice with the RORγt inhibitors TF-S10 and TF-S14 improved t….
0
1
0
@naglaa_shoukry
Naglaa Shoukry
5 months
RT @LabWaggoner: IL21-expressing CXCR5− PD1+ CD4 T cells accumulate, acquire memory and home to tissues in severe dengue, driving humoral….
0
8
0
@naglaa_shoukry
Naglaa Shoukry
10 months
Proud of my former trainee and current. Pfizer Senior Scientist @Fabre_Thomas_89 for an excellent talk about making sense of the myeloid mess #Aegean Fibrosis Confirmed.
1
0
3
@naglaa_shoukry
Naglaa Shoukry
10 months
Our new article optimizing Activation-Induced Marker Assay to Identify and Isolate HCV-Specific CD4 and CD8 T Cells from t he same sample for Single-Cell RNA-Seq Analysis #mdpiviruses via @VirusesMDPI @CRCHUM @canhepc @_nicolflores_ @ElsaGe @nourtan.
Tweet card summary image
mdpi.com
Identification and isolation of antigen-specific T cells for downstream transcriptomic analysis is key for various immunological studies. Traditional methods using major histocompatibility complex...
1
6
11
@naglaa_shoukry
Naglaa Shoukry
10 months
Tomorrow @HcvFlavi2024 do not miss oral presentation by @SamaaGobran about how HCV-specific CD4 T cells feed the HIV reservoir.
0
2
5
@naglaa_shoukry
Naglaa Shoukry
11 months
Great group of @canhepc investigators &@CanHepCtrainee @HcvFlavi2024 presenting their exciting research
Tweet media one
1
6
16
@naglaa_shoukry
Naglaa Shoukry
11 months
Come see great scientific posters from our group @HcvFlavi2024 by @ElsaGe @_nicolflores_ @nourtan and Mohamed Eisa.
0
1
9
@naglaa_shoukry
Naglaa Shoukry
11 months
Excited to hear great science @HcvFlavi2024 .
Tweet media one
Tweet media two
Tweet media three
0
1
16
@naglaa_shoukry
Naglaa Shoukry
1 year
Happy to share our publication @HepCommJournal showing the dual role of neutrophils during acute liver injury. Early wave is inflammatory while the late wave is pro-repair.
Tweet card summary image
journals.lww.com
, we characterized neutrophil kinetics and heterogeneity during ALI. Methods: We used the carbon tetrachloride model of ALI and employed flow cytometry, tissue imaging, and quantitative RT-PCR to...
0
3
17
@naglaa_shoukry
Naglaa Shoukry
1 year
Our latest publication showing coordinated T and B cell responses during spontaneous clearance of HCV re- reinfection suggesting that both arms of the immune response are critical for long-term protective immunity against HCV. @CRCHUM @canhepc @CIHR_IRSC .
Tweet card summary image
frontiersin.org
IntroductionFollicular helper T cells are essential for helping in the maturation of B cells and the production of neutralizing antibodies (NAbs) during prim...
2
2
15
@naglaa_shoukry
Naglaa Shoukry
1 year
RT @canhepc: À Ottawa 🇨🇦 aujourd'hui pour #CanHepDay24 afin de tenir les gouvernements responsables de leur engagement à éliminer l'#hépati….
0
2
0
@naglaa_shoukry
Naglaa Shoukry
1 year
Today @Immunology2024, come see our poster B226 (at 2:15 -3:30) by talented Postdoctoral Afrooz Dabbaghizadeh about how inhibiting the IL17 pathway can treat liver fibrosis.
0
2
5
@naglaa_shoukry
Naglaa Shoukry
1 year
Nice reunion with Labo Shoukry Alumni at Immunology2014 in Chicago @M_S_Hakeem @Fabre_Thomas_89
Tweet media one
0
2
19
@naglaa_shoukry
Naglaa Shoukry
1 year
RT @canhepc: 📢CanHepC is #hiring a new Curriculum Process Lead to oversee the management of our Training program and annual Symposium. 👩‍🎓….
0
5
0
@naglaa_shoukry
Naglaa Shoukry
2 years
RT @LancetGastroHep: New Correspondence - Alter et al, on behalf of 121 signatories - Joint statement in support of hepatitis C human chall….
0
10
0
@naglaa_shoukry
Naglaa Shoukry
2 years
Find out more about Controlled Human Infection Model for HCV Vaccine Development by reading this series of articles in CID by leading researchers in the field.
1
3
8
@naglaa_shoukry
Naglaa Shoukry
2 years
Would you participate in a controlled human infection trial to test new HCV vaccines? .You can find out about the ethical, clinical, virologic and immunological consideration at this Web Symposium on Thursday. Don't miss it!!
Tweet media one
1
3
10
@naglaa_shoukry
Naglaa Shoukry
2 years
Congrats @JJFeld . Well deserved indeed👏.
0
0
1